The global interventional cardiology devices market is
expected to reach USD 25.16 billion by 2020, according to a new report by Grand
View Research. Increasing prevalence of cardiovascular diseases coupled with
adoption of minimally invasive surgeries is expected to boost the
interventional cardiology device market over the forecast period. Unhealthy
lifestyle habits such as high alcohol consumption, smoking, and lack of
physical exercise are triggering incidences of cardiovascular diseases.
Furthermore, the number of congenital heart disease patients is on a constant
rise and this acts as a growth driver for the market.
Browse full research report on Global
Interventional Cardiology Devices Market: http://www.grandviewresearch.com/industry-analysis/interventional-cardiology-devices-market-analysis
According to a report published
by the U.S. CDC (Centers for Disease Control and Prevention) in 2011,
congenital heart defects are the most common birth defects in the U.S.,
affecting approximately 1% of the births every year. The treatment of
cardiovascular disorders has changed dramatically due to the introduction of
new drug therapies and devices such as guidewires and stents allowing the
patient to live better quality and longer lives.
The advent of technologically
advanced internal substitutes plays an integral role in this market and
manufacturers focus on developing new products to curb problems associated with
previous versions. For example, the evolution of stents began from bare metal
stents and has now reached a completely new horizon in the form of disappearing
stents (bio-absorbable stents). Stents accounted for over 70% market share
primarily owing to high usage rates in 2013.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Catheters in sync with stent are
expected to register steady growth to reach up to a market size of over USD 2.5
billion in 2020. The growth is primarily driven by primarily the rising demand
for minimally invasive medical procedures in the field of cardiovascular
diseases. Faster patient recovery time and lesser procedure duration are two
most significant factors contributing towards the rising demand of these
medical procedures.
The North America interventional
cardiology device market in 2013 was valued at over USD 5.5 billion, owing to
factors such as the presence of favorable government initiatives encouraging
new product development, sophisticated healthcare infrastructure and increasing
patient awareness levels coupled with relatively higher healthcare expenditures
in the region.
On the other hand, the Asia
Pacific market is expected to reach over USD 6.4 billion by 2022, growing at a
lucrative rate over the forecast period. The growth is attributed to the
presence of large untapped opportunities, rising healthcare expenditure, cardiovascular
disease incidence rate, and disposable income levels. Prominent players
operating in this industry includes Cordis Corporation, Abbott Laboratories,
Medtronic, Inc, Terumo Medical Corporation, B. Braun Melsungen AG, and Boston
Scientific.
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment